What is the definition of Neuroendocrine Tumor?

A neuroendocrine tumor (NET) is a rare type of tumor that arises from specialized body cells called neuroendocrine cells. These cells have traits of both nerve cells and hormone-producing cells, and release hormones into the blood in response to signals from the nervous system. Because a neuroendocrine tumor arises from cells that produce hormones, the tumor can also produce hormones. Neuroendocrine tumors can develop anywhere in the body, but most occur in the digestive tract, pancreas, rectum, lungs, or appendix. They can be non-cancerous (benign) or cancerous (malignant). They usually grow slowly over many years, but there are fast-growing forms. There are many types of neuroendocrine tumors, but most are classified as one of two main types:
  • Carcinoid tumors - NETs that most commonly arise in the digestive tract, lungs, appendix or thymus. They can also grow in the lymph nodes, brain, bone, gonads (ovaries and testes) or skin.
  • Pancreatic neuroendocrine tumors (also called islet cell tumors) - NETs that typically arise in the pancreas, although they can occur outside the pancreas.

A pheochromocytoma is another, rarer type of NET that usually develops in the adrenal gland, but can also arise in other parts of the body.

Signs and symptoms depend on the tumor's type, size and location; whether it produces hormones; and whether it has spread to other parts of the body (metastasized). NETs are typically described as functional or nonfunctional. Functional NETs produce a specific set of symptoms due to the production of excess hormones, while non-functional NETs generally do not cause specific symptoms. In many cases, a person has no symptoms until the tumor spreads to the liver and/or impairs the function of an organ or system. This can make NETs very hard to diagnose. The majority of NETs are not inherited and occur sporadically in people with no family history of NETs. However, some NETs are associated with a hereditary cancer or tumor syndrome such as multiple endocrine neoplasia type 1 (most commonly), Von Hippel-Lindau disease, tuberous sclerosis, or neurofibromatosis type 1 (NF1). Inheritance of each of these is autosomal dominant. Treatment of NETs depends on many factors such as the tumor's type, location, aggressiveness, and hormone-producing capabilities; as well as whether it has metastasized. Management options may include surveillance, surgery to remove the tumor and/or surrounding tissue, and various non-surgical therapies to shrink the tumor, stop it from growing, or manage symptoms.

What are the alternative names for Neuroendocrine Tumor?

  • Neuroendocrine neoplasia
  • Neuroendocrine neoplasm
  • Condition: Cerebellopontine Angle Tumors
  • Journal: Neurocirugia (English Edition)
  • Treatment Used: Endoscopic Retrosigmoid
  • Number of Patients: 40
  • Published —
This study tested the safety and efficacy of using endoscopic retrosigmoid to treat patients with cerebellopontine angle tumors.
  • Condition: Pulmonary Large Cell Neuroendocrine Carcinoma
  • Journal: The Journal of international medical research
  • Treatment Used: Albumin-Bound Paclitaxel plus Platinum-Based Chemotherapy with Radiotherapy and Durvalumab
  • Number of Patients: 1
  • Published —
The study researched the use of albumin-bound paclitaxel plus platinum-based chemotherapy combined with radiotherapy and durvalumab in treating pulmonary large cell neuroendocrine carcinoma.
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 3000
  • Start Date: March 22, 2000
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma